Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 30, 2019	CT ORDER	CT ORDER	9999999997-19-003600.pdf 9999999997-19-003600.rtf View HTML
April 26, 2019	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-19-122303.pdf 0001193125-19-122303.rtf 0001193125-19-122303.xls View HTML
April 26, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-122326.pdf 0001193125-19-122326.rtf 0001193125-19-122326.xls View HTML
April 18, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-109907.pdf 0001193125-19-109907.rtf 0001193125-19-109907.xls View HTML
April 12, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-010589.pdf 0000899243-19-010589.rtf View HTML
April 12, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-010587.pdf 0000899243-19-010587.rtf View HTML
April 12, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-010588.pdf 0000899243-19-010588.rtf View HTML
April 12, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-010591.pdf 0000899243-19-010591.rtf View HTML
April 12, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-010590.pdf 0000899243-19-010590.rtf View HTML
April 10, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-102254.pdf 0001193125-19-102254.rtf 0001193125-19-102254.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax